Normal Endometrial Thickness in Postmenopausal Women
In postmenopausal women not on estrogen therapy, a normal endometrial thickness is ≤4 mm, with this threshold providing nearly 100% negative predictive value for endometrial cancer.
Clinical Threshold and Diagnostic Implications
The ACR Appropriateness Criteria (2020) establishes 4 mm as the critical cutoff for postmenopausal women 1. This measurement represents the double-layer thickness (both endometrial layers combined) on transvaginal ultrasound.
Key Clinical Thresholds:
- ≤4 mm: Normal; negative predictive value for cancer approaches 100% 1
- ≥5 mm: Abnormal; warrants endometrial tissue sampling 1
Supporting Evidence and Nuances
The 4 mm threshold is consistently validated across multiple studies:
Research data demonstrates that asymptomatic postmenopausal women typically have mean endometrial thickness of 1.4-2.3 mm 2, 3. The measurement varies slightly with years since menopause - averaging 2.3 mm in the first 5 years post-menopause, decreasing to 1.8 mm from 5-13 years, then minimally increasing thereafter 3.
Important Clinical Caveats:
Incomplete visualization is a critical pitfall. Non-endometrioid cancers (serous, clear cell, carcinosarcoma) are more likely to have incompletely visualized endometria (34% vs 9.1% for endometrioid types), which can lead to missed diagnoses 4. When the endometrium cannot be adequately visualized on transvaginal ultrasound, tissue sampling should be performed regardless of measured thickness.
The 4 mm cutoff may miss approximately 5.6% of cancers even when the endometrium is fully visualized 4. This underscores why any postmenopausal bleeding mandates endometrial sampling regardless of ultrasound findings 1.
Risk Factors for Pathology
Women with BMI ≥25 kg/m² have increased risk of endometrial pathology (OR=1.132) 5. Endometrial thickness ≥4 mm itself is a risk factor (OR=7.927) for underlying pathology in asymptomatic women 5.
Practical Application:
- Asymptomatic women with ET ≤4 mm: Reassurance; no further workup needed
- Asymptomatic women with ET ≥5 mm: Consider hysteroscopy and biopsy, especially if obesity, diabetes, or nulliparity present 5, 6
- Any postmenopausal bleeding: Endometrial sampling required regardless of thickness 1
- Incomplete endometrial visualization: Proceed directly to tissue sampling 4
The measurement precision is high with long-term variability <1 mm between observers 3, making transvaginal ultrasound a reliable first-line screening tool when properly performed.